An ethical framework for responding to drug shortages in pediatric oncology

Jill C. Beck, Laurie D. Smith, Bruce G. Gordon, Jeremy R. Garrett

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

The frequency of drug shortages has increased considerably over the last decade. Important ethical issues arise whenever the supply of an effective drug is insufficient to meet demand. Using the ethical principles of beneficence, non-maleficence, and justice, institutions can guide prioritization of drug distribution before a shortage occurs to avoid unfair and unethical distribution of resources. This analysis will give a historical context for drug shortages, identify, and explore the central ethical concerns raised by drug shortages, and propose an ethical framework for addressing them in the context of pediatric oncology. Pediatr Blood Cancer 2015;62:931-934.

Original languageEnglish (US)
Pages (from-to)931-934
Number of pages4
JournalPediatric Blood and Cancer
Volume62
Issue number6
DOIs
StatePublished - Jun 1 2015

Fingerprint

Pediatrics
Pharmaceutical Preparations
Beneficence
Social Justice
Ethics
Neoplasms

Keywords

  • Chemotherapy
  • Ethics
  • Pediatric hematology/oncology
  • Psychosocial
  • Support care

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

An ethical framework for responding to drug shortages in pediatric oncology. / Beck, Jill C.; Smith, Laurie D.; Gordon, Bruce G.; Garrett, Jeremy R.

In: Pediatric Blood and Cancer, Vol. 62, No. 6, 01.06.2015, p. 931-934.

Research output: Contribution to journalReview article

@article{5564121523934695884712789d078383,
title = "An ethical framework for responding to drug shortages in pediatric oncology",
abstract = "The frequency of drug shortages has increased considerably over the last decade. Important ethical issues arise whenever the supply of an effective drug is insufficient to meet demand. Using the ethical principles of beneficence, non-maleficence, and justice, institutions can guide prioritization of drug distribution before a shortage occurs to avoid unfair and unethical distribution of resources. This analysis will give a historical context for drug shortages, identify, and explore the central ethical concerns raised by drug shortages, and propose an ethical framework for addressing them in the context of pediatric oncology. Pediatr Blood Cancer 2015;62:931-934.",
keywords = "Chemotherapy, Ethics, Pediatric hematology/oncology, Psychosocial, Support care",
author = "Beck, {Jill C.} and Smith, {Laurie D.} and Gordon, {Bruce G.} and Garrett, {Jeremy R.}",
year = "2015",
month = "6",
day = "1",
doi = "10.1002/pbc.25461",
language = "English (US)",
volume = "62",
pages = "931--934",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - An ethical framework for responding to drug shortages in pediatric oncology

AU - Beck, Jill C.

AU - Smith, Laurie D.

AU - Gordon, Bruce G.

AU - Garrett, Jeremy R.

PY - 2015/6/1

Y1 - 2015/6/1

N2 - The frequency of drug shortages has increased considerably over the last decade. Important ethical issues arise whenever the supply of an effective drug is insufficient to meet demand. Using the ethical principles of beneficence, non-maleficence, and justice, institutions can guide prioritization of drug distribution before a shortage occurs to avoid unfair and unethical distribution of resources. This analysis will give a historical context for drug shortages, identify, and explore the central ethical concerns raised by drug shortages, and propose an ethical framework for addressing them in the context of pediatric oncology. Pediatr Blood Cancer 2015;62:931-934.

AB - The frequency of drug shortages has increased considerably over the last decade. Important ethical issues arise whenever the supply of an effective drug is insufficient to meet demand. Using the ethical principles of beneficence, non-maleficence, and justice, institutions can guide prioritization of drug distribution before a shortage occurs to avoid unfair and unethical distribution of resources. This analysis will give a historical context for drug shortages, identify, and explore the central ethical concerns raised by drug shortages, and propose an ethical framework for addressing them in the context of pediatric oncology. Pediatr Blood Cancer 2015;62:931-934.

KW - Chemotherapy

KW - Ethics

KW - Pediatric hematology/oncology

KW - Psychosocial

KW - Support care

UR - http://www.scopus.com/inward/record.url?scp=84927910672&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927910672&partnerID=8YFLogxK

U2 - 10.1002/pbc.25461

DO - 10.1002/pbc.25461

M3 - Review article

C2 - 25732614

AN - SCOPUS:84927910672

VL - 62

SP - 931

EP - 934

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 6

ER -